Connect with us

Technology

Plethy and VBW Join Forces to Transform MSK Healthcare with Data-Driven Innovation

Published

9 hours ago

on

SAN JOSE, Calif., Jan. 9, 2025 /PRNewswire/ — The rapidly evolving Musculoskeletal (MSK) healthcare landscape demands innovative, cost-effective solutions that empower patients and improve outcomes. Rising to the challenge, Plethy, Inc., a digital health leader, has partnered with Viscogliosi Brothers through its investment office, Viscogliosi Brothers Watermark Holdings (VBW), which is dedicated to investing in MedTech innovation, forming a groundbreaking long-term collaboration. Together, they aim to transform how personalized, data-driven MSK care is delivered, setting a new standard in HealthTech and InsurTech while addressing the critical needs of patients, providers, and payors.

Redefining MSK care with data-driven insights and personalized recovery solutions

As part of this strategic alignment, John J. Viscogliosi will join the Plethy board, bringing his deep expertise in scaling healthcare companies and driving innovation in the MSK space. His involvement highlights both organizations’ commitment to visionary leadership in digital MSK care.

The partnership unites Plethy’s award-winning, data-driven patient engagement platform with VB’s extensive expertise in scaling MSK solutions to meet the demands of payors and providers alike. Together, they are poised to tackle the critical need for cost-effective, personalized care solutions by leveraging cutting-edge technology and data-driven analytics.

Plethy’s solutions align seamlessly with the growing demands of HealthTech and InsurTech markets. Plethy’s current client base includes self-insured enterprises, insurance carriers, state funds, captives, medical groups, and health systems, reflecting the platform’s adaptability across diverse healthcare and insurance sectors. Plethy’s innovative solutions have transformed patient care by enabling engagement at home and providing predictive analytics to empower clinicians for tailored recovery plans. VB complements this with its proven track record of scaling neuromusculoskeletal companies, improving care quality, and reducing costs through strategic investments and healthcare innovations.

Key Benefits of the Partnership:

Empowered Patients and Quality Outcomes: Patients actively engaged in their recovery journey, leading to measurable outcomes that providers and payors expect.

Data-Driven Insights: Real-time recovery analytics for clinicians to monitor progress and make evidence-based, personalized decisions.

Meeting Evolving Payor Needs: The partnership addresses the need for maximizing clinical outcomes while ensuring cost efficiency, accelerating patients’ return-to-life and work.

“This partnership is a testament to how the MSK healthcare landscape is being reshaped to meet the demands of an evolving industry. By aligning VB’s proven adaptability with Plethy’s innovative platform, we are creating a future where personalized, data-driven care defines excellence. Together, we will lead the transformation of digital MSK solutions, ensuring a profound and sustainable impact across the healthcare ecosystem.” said Anthony G. Viscogliosi, Principal of Viscogliosi Brothers, LLC.

“We are excited to partner with Plethy, a leader in digital health. Together, we’ll set new benchmarks in MSK care, delivering quality and efficiency that the healthcare industry demands.” said John J. Viscogliosi, Chairman of the Board of Directors and & Member of the Investment Committee at Viscogliosi Brothers Watermark Holdings.

“This partnership with VBW reinforces our commitment to transforming digital MSK care. By joining forces, we’ll empower clinicians, enhance patient experiences, and achieve impactful outcomes.” said Raja Sundaram, CEO of Plethy, Inc.

“This partnership leverages advanced analytics and personalized care to deliver better outcomes for patients while addressing healthcare’s cost-efficiency demands.” said Kerem Mavituncalilar, CEO of Viscogliosi Brothers Watermark Holdings.

This collaboration solidifies Plethy and VB as leaders in advancing the MSK healthcare industry. Their combined expertise will drive innovation, improve patient outcomes, and deliver system-wide cost reductions, ensuring that digital MSK solutions become a reality across multiple buying centers and payors.

About Plethy, Inc.: Plethy, Inc. is a leading healthcare technology company at the forefront of patient care and recovery analytics for musculoskeletal disorders, pioneering the use of AI to analyze real-time data for comprehensive, personalized care plans. For more information, visit www.plethy.com.

Viscogliosi Brothers, LLC.  (“VB”) is a New York City-based private equity and venture capital firm specializing in the neuromusculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. For more information, visit https://www.vbllc.com/  

Viscogliosi Brothers Watermark LLC (“VBW”) is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity’s well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit https://vbwholdings.com/.

Plethy, Inc.:  Brooke Whitebread, brooke@plethy.com, 747-300-7275

Viscogliosi Brothers, LLC: Ceylan Kendir, ceylank@vbwatermarkholdings.com, +90 (532) 476-4343

View original content to download multimedia:https://www.prnewswire.com/news-releases/plethy-and-vbw-join-forces-to-transform-msk-healthcare-with-data-driven-innovation-302346610.html

SOURCE Plethy, Inc

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TriNetX’s Founding CEO Announces Plans to Step Down

Published

57 minutes ago

on

January 9, 2025

By

After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board

CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ — TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step down from his operating role on March 31, 2025. Gadi founded TriNetX in 2014 and has served as President and CEO in the succeeding 11 years. Gadi will continue to serve on TriNetX’s Board of Directors and will be an Advisor to Carlyle, TriNetX’s majority investor.

“It has been an honor to build TriNetX and be part of such an outstanding team. I want to thank TriNetX’s employees, customers, and shareholders for the support they have shown me. With the talent and passion of our people I am immensely confident in TriNetX’s continued success,” said Lachman. “Together, we have built the largest global platform for clinical research, with data from over 25 countries and tens of millions of queries a month. Our solutions are moving clinical research to a whole different level and saving lives on a massive scale, across all therapeutic areas.”

During the transition period, Jeff Margolis, a current TriNetX Director, will serve as Executive Chairman to ensure continuity in leadership and governance while a CEO search is conducted.

Margolis said, “I have had the distinct privilege of serving on the Board alongside Gadi and partnering with him for 11 years. On behalf of the Board, we thank Gadi for shaping and leading TriNetX to become the world’s top ecosystem of real-world data and real-world evidence serving life sciences and the broader healthcare industry. I look forward to working with him and the rest of the Board over the next months to execute a successful transition of leadership.”

Joe Bress, Partner and Global Co-Head of Healthcare for Carlyle, TriNetX’s lead investor, added, “We have been thrilled to partner with Gadi since our initial investment in TriNetX over four years ago. Thanks to his disciplined leadership, TriNetX is one of the few companies that has sustained profitability even during periods of high growth. Gadi has built the company up to an exciting point, paving the way for a new leader to take the business into its next chapter of growth and success.”

Through this leadership transition, TriNetX remains steadfast in its mission to advance global healthcare through the power of real-world data. The Board, leadership team, and employees are united in their commitment to driving continued innovation and delivering success for customers and partners, all while building on Gadi’s exceptional legacy.

About TriNetX, LLC

TriNetX is a global network of healthcare organizations and life sciences companies dedicated to advancing real-world research and expediting the development of new therapies. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, please visit TriNetX at www.trinetx.com or follow TriNetX on LinkedIn.

Media Contact
TriNetX
Michelle Fleming, Chief Marketing Officer
Email: Michelle.Fleming@TriNetX.com

Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/trinetxs-founding-ceo-announces-plans-to-step-down-302347367.html

Continue Reading

Technology

Stellus Private Credit BDC Announces $0.36 First Quarter 2025 Regular Dividend, Payable Monthly in Increments of $0.12 in January, February, and March 2025

Published

57 minutes ago

on

January 9, 2025

By

HOUSTON, Jan. 9, 2025 /PRNewswire/ — Stellus Private Credit BDC (“the Company”) announced that its Board of Trustees has declared a monthly dividend of $0.12 for each of January, February, and March, totaling $0.36 per share in the aggregate for the first quarter of 2025. The regular dividend of $0.36 per share will be paid to shareholders of record in January, February, and March 2025.

Summary of First Quarter 2025 Regular Monthly Dividends

Declared

Record Date

Payment Date

Amount per Share

1/9/2025

1/10/2025

1/31/2025

$0.12

1/9/2025

2/3/2025

2/28/2025

$0.12

1/9/2025

3/3/2025

3/31/2025

$0.12

About Stellus Private Credit BDC

The Company is an externally-managed, closed-end, non-diversified investment management company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing primarily in private middle-market companies (typically those with $5.0 million to $50.0 million of EBITDA (earnings before interest, taxes, depreciation and amortization)) through first lien (including unitranche) loans, second lien loans and unsecured debt financing, with corresponding equity co-investments. The Company’s investment activities are managed by its investment adviser, Stellus Private BDC Advisor, LLC.

Forward-Looking Statements

Statements included herein may contain “forward-looking statements” which relate to future performance or financial condition. Statements other than statements of historical facts included in this press release, including statements about COVID-19 and its impacts, may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of assumptions, risks and uncertainties, which change over time. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors, including those described from time to time in filings by the Company with the Securities and Exchange Commission including the final prospectus that will be filed with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts
Stellus Private Credit BDC
W. Todd Huskinson, Chief Financial Officer
(713) 292-5414
thuskinson@stelluscapital.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/stellus-private-credit-bdc-announces-0-36-first-quarter-2025-regular-dividend-payable-monthly-in-increments-of-0-12-in-january-february-and-march-2025–302347311.html

SOURCE Stellus Private Credit BDC

Continue Reading

Technology

MongoDB, Inc. to Present at the 27th Annual Needham Growth Conference

Published

57 minutes ago

on

January 9, 2025

By

NEW YORK, Jan. 9, 2025 /PRNewswire/ — MongoDB, Inc. (NASDAQ: MDB) today announced that Chief Operating Officer and Chief Financial Officer, Michael Gordon, and Senior Vice President of Finance, Serge Tanjga, will present virtually at the 27th Annual Needham Growth Conference.

The MongoDB presentation is scheduled for Thursday, January 16, 2025, at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the MongoDB investor relations website at https://investors.mongodb.com/news-events/events. A replay of the webcast will also be available for a limited time.

About MongoDB
Headquartered in New York, MongoDB’s mission is to empower innovators to create, transform, and disrupt industries by unleashing the power of software and data. Built by developers, for developers, MongoDB’s developer data platform is a database with an integrated set of related services that allow development teams to address the growing requirements for today’s wide variety of modern applications, all in a unified and consistent user experience. MongoDB has tens of thousands of customers in over 100 countries. The MongoDB database platform has been downloaded hundreds of millions of times since 2007, and there have been millions of builders trained through MongoDB University courses. To learn more, visit mongodb.com.

Investor Relations
Brian Denyeau
ICR for MongoDB
646-277-1251
ir@mongodb.com

Media Relations
MongoDB PR
press@mongodb.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mongodb-inc-to-present-at-the-27th-annual-needham-growth-conference-302347475.html

SOURCE MongoDB, Inc.

Continue Reading

Trending